Showing results (81-90 of 89) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Plos One|March 25, 2016
Glycosylation Status of CD43 Protein Is Associated with Resistance of Leukemia Cells to CTL-Mediated CytolysisKana Hasegawa, Satomi Tanaka, Fumihiro Fujiki, et al.International Journal of Cancer|May 13, 2016
Association of WT1 IgG antibody against WT1 peptide with prolonged survival in glioblastoma multiforme patients vaccinated with WT1 peptideYusuke Oji, Naoya Hashimoto, Akihiro Tsuboi, et al.Circulation. Heart Failure|November 22, 2021
Contemporary Management of Cardiogenic Shock: A RAND Appropriateness Panel ApproachAlastair G Proudfoot, Antonis Kalakoutas, Susanna Meade, et al.International Journal of Cancer|January 12, 2018
WT1 peptide-based immunotherapy for advanced thymic epithelial malignanciesYusuke Oji, Masayoshi Inoue, Yoshito Takeda, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 11, 2014
Wilms tumor gene (WT1) peptide-based cancer vaccine combined with gemcitabine for patients with advanced pancreatic cancerSumiyuki Nishida, Shigeo Koido, Yutaka Takeda, et al.Nature Medicine|November 7, 2017
The activated conformation of integrin β7 is a novel multiple myeloma-specific target for CAR T cell therapyNaoki Hosen, Yukiko Matsunaga, Kana Hasegawa, et al.Cancers|January 21, 2023
WT1 Trio Peptide-Based Cancer Vaccine for Rare Cancers Expressing Shared Target WT1Yusuke Oji, Naoki Kagawa, Hideyuki Arita, et al.Science Translational Medicine|February 16, 2022
Selective targeting of multiple myeloma cells with a monoclonal antibody recognizing the ubiquitous protein CD98 heavy chainKana Hasegawa, Shunya Ikeda, Moto Yaga, et al.European Journal of Heart Failure|September 16, 2025
Impact of comorbidity burden on outcome in patients with cardiogenic shock: A Cardiogenic Shock Working Group analysisJonas Sundermeyer, Song Li, Van-Khue Ton, et al.Pageof 9